COMMUNIQUÉS West-GlobeNewswire

Philips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasound
02/06/2026
June 2, 2026 Philips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasound AI-powered workflow automation helps clinicians acquire high- [...]
Premier Health of America Announces Anticipated Delay in Filing Interim Financial Statements and Application for Management Cease Trade Order
02/06/2026
MONTREAL, June 02, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA (TSX-V: PHA) ( “Premier Health” , or the “Company” ) announces that the Company’s unaudited interim financial statements and the related management’s [...]
Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System
02/06/2026
A leading academic center becomes the first user in the Southeast, Mid-Atlantic region HINGHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative [...]
Bay Area Lyme Ventures Invests in Galaxy Diagnostics to Advance Tick-Borne Disease Testing
02/06/2026
Partnership Aims to Accelerate Innovation in Diagnostic Tools for Patients with Complex Tick and Vector-Borne Illnesses DURHAM, NC., June 02, 2026 (GLOBE NEWSWIRE) -- Galaxy Diagnostics , a leader in advanced vector- [...]
Evosep and Molecular You Announce Strategic Collaboration to Scale Standardized Multi-Omic Testing Globally
02/06/2026
SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) -- Evosep and Molecular You today announced a strategic collaboration to advance standardized, high-throughput multi-omic testing for personalized biomarker profiling. The [...]
ASHA: This Summer, Protect Your Hearing Without Missing the Fun
02/06/2026
From Fireworks to Sports and Concerts, Simple Steps Can Help Protect Your Hearing Rockville, MD, June 02, 2026 (GLOBE NEWSWIRE) -- With a summer packed full of events and activities—World Cup matches, July 4th and [...]
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Advancing Proprietary Solutions Focused on Nanotechnology-Enabled Drug Delivery, AI-Enhanced Biomedical Infrastructure
02/06/2026
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic [...]
Scene Health Releases New Guide on Medication Adherence Support for Leaders Advancing Rural Health Transformation
02/06/2026
BALTIMORE, June 02, 2026 (GLOBE NEWSWIRE) -- Scene Health announces the release of its new guide, Transforming Rural Healthcare through Medication Adherence Support , designed for U.S. health leaders strengthening their [...]
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm
02/06/2026
Bunkerhill Health’s FDA-cleared ECG-EF algorithm for the detection of reduced ejection fraction becomes the first cleared AI-ECG algorithm available through MyoVista Insights, advancing HeartSciences’ SaaS-based, [...]
Cardiff Oncology Announces Presentation of Positive Results from its Randomized, Controlled Phase 2 Trial of Onvansertib in First-Line RAS-Mutated mCRC at the 2026 ASCO Annual Meeting
02/06/2026
- The trial achieved its primary goal of selecting the efficacious and safe dose of onvansertib + standard-of-care (SoC) regimen for the registrational program - - 30 mg onvansertib + FOLFIRI/bevacizumab arm showed a [...]
Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
02/06/2026
Daix (France), New York City (New York, United States), le 2 juin 2026 – Inventiva (Euronext Paris et NASDAQ: IVA ) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement d’une [...]
Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors
02/06/2026
Appointments Add Deep Biopharmaceutical Commercial Strategy, Clinical and Finance Expertise as Company Advances Toward Potential Cytisinicline Approval and Launch SEATTLE and VANCOUVER, British Columbia, June 02, 2026 ( [...]
Quoin Pharmaceuticals Submits IND Application for QRX003 in Peeling Skin Syndrome
02/06/2026
-First ever IND submission for this disease, which has no current treatment or cure- -Quoin plans Phase 2 study initiation in 2H 2026- -Submission supported by positive initial clinical data from Investigator-led [...]
Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026
02/06/2026
New findings from the industry’s largest real-world TMS database reinforce NeuroStar’s leadership in advancing evidence-based mental health care MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ [...]
Signati™ Medical Receives FDA IDE Approval for Pivotal Study of the Separo™ Vessel Sealing System
02/06/2026
Providence, RI, June 02, 2026 (GLOBE NEWSWIRE) -- Signati™ Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational Device Exemption (IDE) application for [...]
Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris
02/06/2026
Daix (France), New York City (New York, United States), June 2, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA ) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website
02/06/2026
New dashboard at betabionics.com shows every patient, every baseline, every outcome, with no filters and no fine print IRVINE, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering [...]
Oncolytics Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer
02/06/2026
SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage company developing pelareorep, an investigational, systemically active [...]
Myriad Genetics Names Raj Jampa as New Chief Technology Officer
02/06/2026
SALT LAKE CITY, June 02, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces today the appointment of Raj Jampa as chief technology [...]

Pages